Clinical Trials Directory

Trials / Completed

CompletedNCT00875537

Neurogenic Mechanisms in Burning Mouth Syndrome

Neurogenic Mechanisms in Burning Mouth Syndrome With Focus on Localization and Desensibilization of Vanilloid Receptor TRPV1

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
University of Copenhagen · Academic / Other
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Burning mouth syndrome (BMS) is characterized by a bilateral burning sensation in the anterior tongue, hard palate and lips in the absence of any clinical or laboratory findings. The term syndrome implicates the simultaneous presence of oral dryness (xerostomia) and altered taste (dysgeusia) in addition to the burning sensation in the oral mucosa. BMS is most often seen in women and is more frequent during menopause. The etiology and pathogenesis are still unclear but recent studies suggest that BMS is a neuropathic pain condition. The objectives of the study are: * To clarify potential neurogenic mechanisms behind BMS using immunohistochemistry (IH) to characterize the localization and distribution of peripheral nerve fibres, neuropeptides like substance P, calcitonin gene-related peptide, nerve growth factor, nerve growth factor receptor, PGP 9.5 neuronal marker and TRPV1 as well as inflammatory/structural changes. * To perform a randomized double blind cross-over intervention study to examine the efficacy and safety of topical application of capsaicin oral gel (on the tongue) to relieve the burning sensation in patients with BMS.

Detailed description

Data which support the hypothesis that BMS is a neuropathic pain condition include amongst others a recent clinically controlled study that has shown up-regulation of TRPV1-positive nerve fibres in tongue mucosa in patients with BMS. The vanilloid receptor-1 (TRPV1) is a voltage-dependent cation channel expressed by the unmyelinated C-nociceptive nerve fibres and the receptor may be activated by capsaicin (from chili peppers), heat and H+. Capsaicin binds to the TRPV1 receptor causing depolarization of the C-nociceptors. Prolonged activation of these neurons by capsaicin depletes pre-synaptic substance P and makes them unable to report pain.

Conditions

Interventions

TypeNameDescription
OTHERCapsaicin oral gel 0.025%Application 3 times daily for 14 days on the tongue, followed by 14 days wash-out
OTHERCapsaicin oral gel 0.01%Application 3 times daily for 14 days on the tongue, followed by 14 days wash-out

Timeline

Start date
2009-01-01
Primary completion
2010-04-01
Completion
2010-06-01
First posted
2009-04-03
Last updated
2017-03-14

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00875537. Inclusion in this directory is not an endorsement.